Unexpected marked seizure improvement in paediatric epilepsy surgery candidates

Christina E Hoei-Hansen1, René Mathiasen1, Peter Uldall2

  • 1Department of Paediatrics, University Hospital Rigshospitalet, Copenhagen, Denmark.

Seizure
|December 13, 2016
PubMed

Insights

Some children with refractory epilepsy achieve seizure freedom unexpectedly during evaluation for epilepsy surgery. This improvement sometimes leads to withdrawal from the surgical program, with a significant portion remaining seizure-free long-term.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Epilepsy surgery is typically reserved for medically refractory cases, assuming continued seizures.
  • Unexpected seizure remission can occur during the pre-surgical evaluation period.

Purpose of the Study:

  • To determine the incidence of children withdrawn from epilepsy surgery programs due to spontaneous seizure improvement.
  • To characterize these cases and their long-term outcomes.

Main Methods:

  • Retrospective review of 173 children under 18 with medically refractory epilepsy evaluated for surgery (1996-2010).
  • Medical records analyzed in 2012 and 2015 to identify patients withdrawn from the program.
  • Detailed analysis of seizure history, treatment changes, and outcomes for withdrawn patients.

Main Results:

  • Thirteen patients (7.5%) were withdrawn due to marked seizure improvement by 2012.
  • Six of these 13 patients remained seizure-free by 2015, with improvement linked to AED changes or febrile episodes.
  • The withdrawn group had a history of significant seizure burden and normal IQs; etiologies included focal cortical dysplasia and heterotopia.

Conclusions:

  • Spontaneous seizure control is a possibility during the epilepsy surgery evaluation process.
  • This phenomenon can lead to successful program withdrawal and sustained seizure freedom in some pediatric epilepsy cases.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K